2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Pain, Postoperative
4
Pancreatic Neoplasms
3
Lung Neoplasms
2
Liver Neoplasms
2
Agnosia
2
Uterine Cervical Neoplasms
1
Thoracic Neuritis
1
Stomach Neoplasms
1
Reperfusion Injury
1
Prostatic Neoplasms
1
Neoplasms
1
Leiomyoma
1
Inflammation
1
Endometrial Neoplasms
1
End Stage Liver Disease
1
Colonic Neoplasms
1
Breast Neoplasms
1
Breast Cancer Female
1
Bites and Stings
1
Biliary Tract Neoplasms
1
Adenomyosis
1
Acute Pain
1
Interventions
Exercise
5
Vitamin D
3
Resistance Training
3
Omeprazole
3
Etanercept
3
Dexmedetomidine
3
Ascorbic Acid
3
salicylsalicylic acid
2
palbociclib
2
epigallocatechin gallate
2
XENP 1595
2
Tea
2
Tablets
2
Surgical Procedures, Operative
2
Sufentanil
2
Spironolactone
2
Probiotics
2
Pioglitazone
2
Oxycodone
2
Nutrition Assessment
2
Morphine
2
Metformin
2
Ketorolac
2
Infliximab
2
Ibuprofen
2
Fish Oils
2
Endurance Training
2
Colchicine
2
Blood Specimen Collection
2
Aspirin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammation
×
Analgesia, Patient-Controlled
×
Clear all
NCT01367418
2012-03-19
AIMS
Örebro University, Sweden
Phase 3
Completed
26 enrolled